Skip to main content

Schlossberg Mark A's Form 4 filing

Cytokinetics Inc (CYTK) · filed Mar 15, 2022

Accession no.
0001061983-22-000077
Filed
Mar 15, 2022
Trade date
Mar 15, 2022
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $855.7K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schlossberg Mark ACIK 0001520533Officer (SVP - Legal & General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 15, 2022Common StockMOption exerciseAcquired+30,818$7.03+$216,650.5498,605Direct
Mar 15, 2022Common StockMOption exerciseAcquired+4,803$14.40+$69,163.2103,408Direct
Mar 15, 2022Common StockMOption exerciseAcquired+25,196$14.40+$362,822.4128,604Direct
Mar 15, 2022Common StockSSaleDisposed−25,196$33.96−$855,656.16103,408Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 15, 2022Common StockMOption exerciseDisposed−30,818$0.00$013,938Direct
Mar 15, 2022Common StockMOption exerciseDisposed−4,803$0.00$04,804Direct
Mar 15, 2022Common StockMOption exerciseDisposed−25,196$0.00$025,197Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)